Free Trial
NASDAQ:TLSA

Tiziana Life Sciences (TLSA) Stock Price, News & Analysis

Tiziana Life Sciences logo
$1.54 -0.03 (-1.91%)
As of 07/3/2025 03:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Tiziana Life Sciences Stock (NASDAQ:TLSA)

Key Stats

Today's Range
$1.51
$1.56
50-Day Range
$1.22
$1.78
52-Week Range
$0.63
$1.91
Volume
179,781 shs
Average Volume
474,769 shs
Market Capitalization
$179.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tiziana Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

TLSA MarketRank™: 

Tiziana Life Sciences scored higher than 14% of companies evaluated by MarketBeat, and ranked 2620th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Tiziana Life Sciences.

  • Percentage of Shares Shorted

    0.95% of the float of Tiziana Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tiziana Life Sciences has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tiziana Life Sciences has recently decreased by 16.68%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Tiziana Life Sciences does not currently pay a dividend.

  • Dividend Growth

    Tiziana Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.95% of the float of Tiziana Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tiziana Life Sciences has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tiziana Life Sciences has recently decreased by 16.68%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 2 people have searched for TLSA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Tiziana Life Sciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tiziana Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.82% of the stock of Tiziana Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Tiziana Life Sciences' insider trading history.
Receive TLSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tiziana Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TLSA Stock News Headlines

Have you heard of “E.I.”?
Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing to invest in new "E.I." Tech, which one expert estimates will grow by 200,000%. Becoming bigger than the automobile, PC, and cell phone markets... COMBINED!
See More Headlines

TLSA Stock Analysis - Frequently Asked Questions

Tiziana Life Sciences' stock was trading at $0.6962 at the start of the year. Since then, TLSA shares have increased by 121.2% and is now trading at $1.54.

Tiziana Life Sciences (TLSA) raised $10 million in an initial public offering on the week of November 19th 2018. The company issued 1,000,000 shares at $9.90 per share. Laidlaw & Company (UK) Ltd. served as the underwriter for the IPO.

Shares of TLSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tiziana Life Sciences investors own include NIO (NIO), Advanced Micro Devices (AMD), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Meta Platforms (META), Inovio Pharmaceuticals (INO) and Pfizer (PFE).

Company Calendar

Today
7/04/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TLSA
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
38.50

Miscellaneous

Free Float
70,319,000
Market Cap
$179.95 million
Optionable
Optionable
Beta
-0.05
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:TLSA) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners